Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -9.76% | -.--% | -79.15% |
Feb. 29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | Imagion Biosystems CEO Resigns | MT |
Sales 2021 | 2.86M 1.88M | Sales 2022 | 3.07M 2.02M | Capitalization | 26.91M 17.67M |
---|---|---|---|---|---|
Net income 2021 | -6M -3.94M | Net income 2022 | -9M -5.91M | EV / Sales 2021 | 25.2 x |
Net cash position 2021 | 13.35M 8.77M | Net Debt 2022 | 158K 104K | EV / Sales 2022 | 8.81 x |
P/E ratio 2021 |
-12.7
x | P/E ratio 2022 |
-2.67
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 91.86% |
1 day | -9.76% | ||
3 months | -55.15% | ||
6 months | -84.58% | ||
Current year | -79.15% |
Managers | Title | Age | Since |
---|---|---|---|
Geoff Hollis
DFI | Director of Finance/CFO | - | 20-12-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 17-03-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 17-02-27 |
1st Jan change | Capi. | |
---|---|---|
-79.15% | 1.57M | |
-15.52% | 18.54B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+25.21% | 1.23B | |
-13.90% | 989M | |
-21.76% | 896M | |
-5.01% | 744M | |
-19.85% | 673M | |
+7.31% | 490M |
- Stock Market
- Equities
- IBX Stock